Supurva Healthcare Group, Inc.
SPRV · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.00 | 0.06 | 3.21 |
| FCF Yield | -8.03% | -63.18% | -83.93% | 0.00% |
| EV / EBITDA | -2.77 | -2.15 | -2.77 | 10.97 |
| Quality | ||||
| ROIC | 25.72% | 41.70% | 201.40% | 0.00% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.04 | 0.11 | 0.92 | – |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 59.40% | 91.12% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -2.05 | -1.94 | -1.64 | 9.04 |
| Interest Coverage | -2.79 | -4.49 | -30.94 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |